Cadrenal Therapeutics, Inc To Start Trading Tomorrow

Cadrenal Therapeutics, Inc CVKD IPO will take place January, 20 on the NASDAQ exchange under the ticker CVKD.

The company is offering shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on July 19, 2023.

See also: Benzinga IPO Calendar

About Cadrenal Therapeutics, Inc

Cadrenal Therapeutics, Inc is focused on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease and atrial fibrillation (irregular heartbeat) or AFib

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.